ResMed, Inc. (RMD)
204.00
+2.12
(+1.05%)
USD |
NYSE |
May 18, 11:20
ResMed EPS Diluted (Quarterly) : 2.736 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 0.8995 |
| Intuitive Surgical, Inc. | 2.283 |
| Stryker Corp. | 1.928 |
| Baxter International, Inc. | -0.0291 |
| Abbott Laboratories | 0.6165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 398.73M |
| Revenue (Quarterly) | 1.431B |
| Total Expenses (Quarterly) | 1.033B |
| Enterprise Value | 28.46B |
| Gross Profit Margin (Quarterly) | 61.46% |
| Profit Margin (Quarterly) | 27.86% |
| Earnings Yield | 5.09% |
| Operating Earnings Yield | 6.44% |
| Normalized Earnings Yield | 5.129 |